These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3231947)

  • 1. Stopping rules and estimation problems in clinical trials.
    Hughes MD; Pocock SJ
    Stat Med; 1988 Dec; 7(12):1231-42. PubMed ID: 3231947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical problems in interim analyses, with particular regard to estimation.
    Pocock SJ; Hughes MD
    Control Clin Trials; 1989 Dec; 10(4 Suppl):209S-221S. PubMed ID: 2605969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation issues in clinical trials and overviews.
    Pocock SJ; Hughes MD
    Stat Med; 1990 Jun; 9(6):657-71. PubMed ID: 2145623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of stopping rules on heterogeneity of results in overviews of clinical trials.
    Hughes MD; Freedman LS; Pocock SJ
    Biometrics; 1992 Mar; 48(1):41-53. PubMed ID: 1581492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian predictive approach to interim monitoring in clinical trials.
    Dmitrienko A; Wang MD
    Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical rules for safety monitoring in clinical trials.
    Martens MJ; Logan BR
    Clin Trials; 2024 Apr; 21(2):152-161. PubMed ID: 37877375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.
    Walter SD; Guyatt GH; Bassler D; Briel M; Ramsay T; Han HD
    Stat Med; 2019 Jun; 38(14):2524-2543. PubMed ID: 30887553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of clinical trials with early stopping: an investigation of potential bias.
    Schou IM; Marschner IC
    Stat Med; 2013 Dec; 32(28):4859-74. PubMed ID: 23824994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian Sequential Monitoring of Single-Arm Trials: A Comparison of Futility Rules Based on Binary Data.
    Sambucini V
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pragmatic, adaptive clinical trial design for a rare disease: The FOcal Cerebral Arteriopathy Steroid (FOCAS) trial.
    Park Y; Fullerton HJ; Elm JJ
    Contemp Clin Trials; 2019 Nov; 86():105852. PubMed ID: 31614215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.
    Thall P; Fox P; Wathen J
    Ann Oncol; 2015 Aug; 26(8):1621-8. PubMed ID: 25979922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues in designing sequential stopping rules for monitoring side effects in clinical trials.
    Goldman AI
    Control Clin Trials; 1987 Dec; 8(4):327-37. PubMed ID: 3327653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A note regarding meta-analysis of sequential trials with stopping for efficacy.
    Senn S
    Pharm Stat; 2014; 13(6):371-5. PubMed ID: 25296692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous toxicity monitoring in phase II trials in oncology.
    Ivanova A; Qaqish BF; Schell MJ
    Biometrics; 2005 Jun; 61(2):540-5. PubMed ID: 16011702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.